| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.37 | 0.03 |